Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Epilepsy

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 21 articles:
HTML format



Single Articles


    April 2021
  1. MARSON A, Burnside G, Appleton R, Smith D, et al
    The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
    Lancet. 2021;397:1375-1386.
    PubMed     Abstract available


  2. MARSON A, Burnside G, Appleton R, Smith D, et al
    The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial.
    Lancet. 2021;397:1363-1374.
    PubMed     Abstract available


    December 2020
  3. BERKOVIC SF
    Epileptic encephalopathies of infancy: welcome advances.
    Lancet. 2020;394:2203-2204.
    PubMed    


  4. LAGAE L, Sullivan J, Knupp K, Laux L, et al
    Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial.
    Lancet. 2020;394:2243-2254.
    PubMed     Abstract available


    June 2020
  5. AHMED MA, Abdelnabi M, Almaghraby A, Elkafrawy FR, et al
    Neuropathy, encephalopathy, status epilepticus, and acute intermittent porphyria.
    Lancet. 2020;395:e101.
    PubMed    


    March 2020
  6. CHAMBERLAIN JM, Kapur J, Shinnar S, Elm J, et al
    Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial.
    Lancet. 2020 Mar 20. pii: S0140-6736(20)30611.
    PubMed     Abstract available


  7. APPLETON RE
    Second-line anticonvulsants for paediatric convulsive status epilepticus.
    Lancet. 2020 Mar 20. pii: S0140-6736(20)30674.
    PubMed    


    February 2020
  8. SEN A, Jette N, Husain M, Sander JW, et al
    Epilepsy in older people.
    Lancet. 2020;395:735-748.
    PubMed     Abstract available


    December 2019
  9. FODJO JNS, Makoy YL, Colebunders R
    Epilepsy prevention.
    Lancet. 2019;394:2072.
    PubMed    


    June 2019
  10. THE LANCET
    Epilepsy prevention: an urgent global unmet need.
    Lancet. 2019;393:2564.
    PubMed    


    April 2019
  11. SILBERGLEIT R, Elm JJ
    Levetiracetam no better than phenytoin in children with convulsive status epilepticus.
    Lancet. 2019 Apr 17. pii: S0140-6736(19)30896.
    PubMed    


  12. DALZIEL SR, Borland ML, Furyk J, Bonisch M, et al
    Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial.
    Lancet. 2019 Apr 17. pii: S0140-6736(19)30722.
    PubMed     Abstract available


  13. LYTTLE MD, Rainford NEA, Gamble C, Messahel S, et al
    Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial.
    Lancet. 2019 Apr 17. pii: S0140-6736(19)30724.
    PubMed     Abstract available


    February 2019
  14. THE LANCET
    From wonder and fear: make epilepsy a global health priority.
    Lancet. 2019;393:612.
    PubMed    


    January 2019
  15. THIJS RD, Surges R, O'Brien TJ, Sander JW, et al
    Epilepsy in adults.
    Lancet. 2019 Jan 24. pii: S0140-6736(18)32596.
    PubMed     Abstract available


    August 2018
  16. SEN A, Nashef L
    New regulations to cut valproate-exposed pregnancies.
    Lancet. 2018;392:458-460.
    PubMed    


    July 2018
  17. THE LANCET
    Cannabinoids: just like any other medication?
    Lancet. 2018;392:188.
    PubMed    


    March 2018
  18. VARADKAR S
    Cannabidiol for drop seizures in Lennox-Gastaut syndrome.
    Lancet. 2018;391:1006-1007.
    PubMed    


  19. THIELE EA, Marsh ED, French JA, Mazurkiewicz-Beldzinska M, et al
    Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.
    Lancet. 2018;391:1085-1096.
    PubMed     Abstract available


    October 2016
  20. BAYER R, Johns DM, Galea S
    A false aura of scientific controversy around salt?
    Lancet. 2016;388:2109.
    PubMed    


  21. FRENCH JA, Lawson JA, Yapici Z, Ikeda H, et al
    Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study.
    Lancet. 2016;388:2153-2163.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Epilepsy is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: